New frontiers in tumor marker studies: from biobanking to collaboration in translational research

International Journal of Biological Markers

Volumn 26, Issue 2, 2011, Pages 73-74

  Gion, Massimo ^b   Fabricio, Aline S C ^a  

^a Regional Center for Biomarkers ABO Foundation   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

CYTOPATHOLOGY; HUMAN; NOTE; PRACTICE GUIDELINE; RADIOFREQUENCY IDENTIFICATION; TISSUE SECTION; TRANSLATIONAL RESEARCH; UTERINE CERVIX CYTOLOGY;

BIOLOGICAL SPECIMEN BANKS; HUMANS; MULTICENTER STUDIES AS TOPIC; RADIO FREQUENCY IDENTIFICATION DEVICE; SPECIMEN HANDLING; TRANSLATIONAL RESEARCH; TUMOR MARKERS, BIOLOGICAL;

EID: 79959323464     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2011.8388     Document Type: Note

References (4)

1. Khleif SN, Doroshow JH, Hait WN; For the AACR-FDA-NCI Cancer Biomarkers Collaborative. AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the use of biomarkers in cancer drug development. Clin Cancer Res 2010; 16: 3299-318.
2. Arbyn M, Van Veen EB, Andersson K, et al. Cervicalcytology biobanking in Europe. Int J Biol Markers 2010; 25: 117-25.
3. Nanni U, Spila A, Riondino S, et al. RFID as a new ICT tool to monitor specimen life cycle and quality control in a biobank. Int J Biol Markers 2011; 26: 129-35.
4. Lombardo C, Bottero S, d'Alessandro F, et al. TRAIN: Training through Research Application Italian iNitiative. Int J Biol Markers 2011; 26: 136-8.